// App-Quantinova.ai

: Laboratory Glycemic Markers vs. Continuous Glucose Monitoring (CGM) for Prediction of Neonatal Outcomes in Type 1 Diabetes Pregnancy—An Ancillary Study of the CONCEPTT Trial

Researchers

Presenter

  • CLAIRE L. MEEK

Principal Investigators

  • DIANA TUNDIDOR

  • HELEN R. MURPHY

  • JENNIFER M. YAMAMOTO

  • ELEANOR M. SCOTT

  • DONGDONG MA

  • JOSE HALPERIN

  • DENICE FEIG

Medical Centers

  • N/A

Locations

  • United Kingdom

  • Spain

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 59

  • Hemoglobin A1c

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved